Bone marrow impairment during early [(177)Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?

por Kind, Felix, Michalski, Kerstin, Yousefzadeh-Nowshahr, Elham, Meyer, Philipp T., Mix, Michael, Ruf, Juri
Publicado 2022

Quantitative analysis of regional distribution of tau pathology with (11)C-PBB3-PET in a clinical setting

por Yousefzadeh-Nowshahr, Elham, Winter, Gordon, Bohn, Peter, Kneer, Katharina, von Arnim, Christine A. F., Otto, Markus, Solbach, Christoph, Anderl-Straub, Sarah, Polivka, Dörte, Fissler, Patrick, Strobel, Joachim, Kletting, Peter, Riepe, Matthias W., Higuchi, Makoto, Glatting, Gerhard, Ludolph, Albert, Beer, Ambros J.
Publicado 2022